Cooper Companies (NYSE:COO – Get Rating) had its target price hoisted by Citigroup from $372.00 to $430.00 in a report issued on Monday morning, The Fly reports. Citigroup currently has a buy rating on the medical device company’s stock. Other analysts have also issued research reports about the stock. Mizuho lifted their price objective on […]
Manning & Napier Group LLC acquired a new position in The Cooper Companies, Inc. (NYSE:COO – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 33,523 shares of the medical device company’s stock, valued at approximately $11,085,000. Manning & Napier Group […]
Silvant Capital Management LLC decreased its position in shares of The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 29.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,775 shares of the medical device company’s stock after selling 6,145 shares during the […]
Ceredex Value Advisors LLC reduced its stake in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 47.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 280,985 shares of the medical device company’s stock after selling 253,066 shares during the quarter. Cooper Companies makes […]
Congress Asset Management Co. MA raised its holdings in shares of The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 321,841 shares of the medical device company’s stock after […]